288 related articles for article (PubMed ID: 28590025)
21. p14ARF and p16INK4A, two products of the same gene, are differently expressed in cervical intraepithelial neoplasia.
Bulten J; van der Avoort IA; Melchers WJ; Massuger LF; Grefte JM; Hanselaar AG; de Wilde PC
Gynecol Oncol; 2006 Jun; 101(3):487-94. PubMed ID: 16406113
[TBL] [Abstract][Full Text] [Related]
22. Association between human papillomavirus DNA load and development of cervical intraepithelial neoplasia and cervical cancer.
Huang Y; Huang MN; Li N; Li XG; Li N; Wu LY
Int J Gynecol Cancer; 2008; 18(4):755-60. PubMed ID: 18021222
[TBL] [Abstract][Full Text] [Related]
23. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
White C; Bakhiet S; Bates M; Keegan H; Pilkington L; Ruttle C; Sharp L; O' Toole S; Fitzpatrick M; Flannelly G; O' Leary JJ; Martin CM
Cytopathology; 2016 Aug; 27(4):269-76. PubMed ID: 26932360
[TBL] [Abstract][Full Text] [Related]
24. Assessment of correlation between p16INK4a staining, specific subtype of human papillomavirus, and progression of LSIL/CIN1 lesions: first comparative study.
Razmpoosh M; Sansregret A; Oligny LL; Patey N; Dormoy-Raclet V; Ducruet T; Bouron-Dal Soglio D
Am J Clin Pathol; 2014 Jul; 142(1):104-10. PubMed ID: 24926093
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
Wilting SM; Steenbergen RD; Tijssen M; van Wieringen WN; Helmerhorst TJ; van Kemenade FJ; Bleeker MC; van de Wiel MA; Carvalho B; Meijer GA; Ylstra B; Meijer CJ; Snijders PJ
Cancer Res; 2009 Jan; 69(2):647-55. PubMed ID: 19147580
[TBL] [Abstract][Full Text] [Related]
26. Using p16 immunohistochemistry to classify morphologic cervical intraepithelial neoplasia 2: correlation of ambiguous staining patterns with HPV subtypes and clinical outcome.
Liu Y; Alqatari M; Sultan K; Ye F; Gao D; Sigel K; Zhang D; Kalir T
Hum Pathol; 2017 Aug; 66():144-151. PubMed ID: 28705710
[TBL] [Abstract][Full Text] [Related]
27. Adjunctive use of p16 immunohistochemistry for optimizing management of CIN lesions in a high-risk human papillomavirus-positive population.
Ebisch RMF; Rijstenberg LL; Soltani GG; van der Horst J; Vedder JEM; Hermsen M; Bosgraaf RP; Massuger LFAG; Meijer CJLM; Heideman DAM; van Kemenade FJ; Melchers WJG; Bekkers RLM; Siebers AG; Bulten J
Acta Obstet Gynecol Scand; 2022 Nov; 101(11):1328-1336. PubMed ID: 36177908
[TBL] [Abstract][Full Text] [Related]
28. Investigating Diagnostic Problems of CIN1 and CIN2 Associated With High-risk HPV by Combining the Novel Molecular Biomarker PanHPVE4 With P16INK4a.
van Baars R; Griffin H; Wu Z; Soneji YJ; van de Sandt M; Arora R; van der Marel J; Ter Harmsel B; Jach R; Okon K; Huras H; Jenkins D; Quint W; Doorbar J
Am J Surg Pathol; 2015 Nov; 39(11):1518-1528. PubMed ID: 26379150
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of human papillomavirus genotype by linear array assay in Japanese women with uterine cervical lesions and type 16 physical status by in situ hybridization.
Futai M; Watanabe J; Jobo T; Tsunoda S; Nishimura Y; Watanabe K; Okayasu I; Unno N
Int J Gynecol Cancer; 2009 Nov; 19(8):1396-401. PubMed ID: 20009896
[TBL] [Abstract][Full Text] [Related]
30. p16INK4A immunoexpression and HPV in situ hybridization signal patterns: potential markers of high-grade cervical intraepithelial neoplasia.
Kalof AN; Evans MF; Simmons-Arnold L; Beatty BG; Cooper K
Am J Surg Pathol; 2005 May; 29(5):674-9. PubMed ID: 15832093
[TBL] [Abstract][Full Text] [Related]
31. The possible role of bcl-2 expression in the progression of tumors of the uterine cervix.
Saegusa M; Takano Y; Hashimura M; Shoji Y; Okayasu I
Cancer; 1995 Dec; 76(11):2297-303. PubMed ID: 8635035
[TBL] [Abstract][Full Text] [Related]
32. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis.
Matsuda K; Miura S; Kurashige T; Suzuki K; Kondo H; Ihara M; Nakajima H; Masuzaki H; Nakashima M
Histopathology; 2011 Sep; 59(3):441-51. PubMed ID: 22034884
[TBL] [Abstract][Full Text] [Related]
33. Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities.
Hopman AH; Smedts F; Dignef W; Ummelen M; Sonke G; Mravunac M; Vooijs GP; Speel EJ; Ramaekers FC
J Pathol; 2004 Jan; 202(1):23-33. PubMed ID: 14694518
[TBL] [Abstract][Full Text] [Related]
34. Cytokeratin7 and cytokeratin19 expression in high grade cervical intraepithelial neoplasm and squamous cell carcinoma and their possible association in cervical carcinogenesis.
Lee H; Lee H; Cho YK
Diagn Pathol; 2017 Feb; 12(1):18. PubMed ID: 28212672
[TBL] [Abstract][Full Text] [Related]
35. Chemiluminescent quantitative immunohistochemical p16 INK4A localization as a marker for cervical intraepithelial neoplasias.
Venturoli S; Ambretti S; Mirasoli M; Santini D; Zerbini M; Roda A; Musiani M
Int J Gynecol Pathol; 2008 Oct; 27(4):575-81. PubMed ID: 18753961
[TBL] [Abstract][Full Text] [Related]
36. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
37. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
38. DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri.
Melsheimer P; Vinokurova S; Wentzensen N; Bastert G; von Knebel Doeberitz M
Clin Cancer Res; 2004 May; 10(9):3059-63. PubMed ID: 15131043
[TBL] [Abstract][Full Text] [Related]
39. Dual immunostaining of cervical cytology specimens with atypical squamous cells for p16/Ki-67 does not exclude the existence of a high-grade squamous intraepithelial lesion.
Koo YJ; Hahn HS; Lee IH; Lim KT; Lee KH; Kim HS; Kim TJ; Chun YK; Kim HS; Hong SR
Virchows Arch; 2013 Nov; 463(5):689-96. PubMed ID: 24081504
[TBL] [Abstract][Full Text] [Related]
40. Aberrant promoter methylation can be useful as a marker of recurrent disease in patients with cervical intraepithelial neoplasia grade III.
Terra AP; Murta EF; Maluf PJ; Caballero OL; Brait M; Adad SJ
Tumori; 2007; 93(6):572-9. PubMed ID: 18338492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
